Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02977780
Title INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Patrick Wen, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham ACTIVE_NOT_RECRUITING Birmingham Alabama 35294 United States Details
Massachusetts General Hospital ACTIVE_NOT_RECRUITING Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02115 United States Details
Mayo Clinic ACTIVE_NOT_RECRUITING Rochester Minnesota 55905 United States Details
Columbia University Medical Center ACTIVE_NOT_RECRUITING New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center ACTIVE_NOT_RECRUITING New York New York 10065 United States Details
Cleveland Clinic ACTIVE_NOT_RECRUITING Cleveland Ohio 44195 United States Details
University of Pittsburgh Medical Center ACTIVE_NOT_RECRUITING Pittsburgh Pennsylvania 15232 United States Details
Lifespan / Rhode Island Hospital ACTIVE_NOT_RECRUITING Providence Rhode Island 02903 United States Details
UT MD Anderson Cancer Center COMPLETED Houston Texas 77030 United States Details
Huntsman Cancer Institute ACTIVE_NOT_RECRUITING Salt Lake City Utah 84112 United States Details
University of Virginia Health System COMPLETED Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field